$90m IPO Sets Up Sweden's Calliditas For Phase III Readout

Biotech Sector Listings Defying Pandemic

 
• By Andrew McConaghie
  
Going public
The Nasdaq IPO gears the company up for a US commercial focus
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip